Inactivation of the transforming growth factor-b (TGF-b) pathway occurs often in malignancies of the gastrointestinal (GI) system. However, only a fraction of sporadic GI tumors exhibit inactivating mutations in early stages of cancer formation, suggesting that other mechanisms play a critical role in the inactivation of this pathway. Here, we show a wide range of GI tumors, including those of the stomach, liver and colon in elf þ /À and elf
Inactivation of the transforming growth factor-b (TGF-b) pathway occurs often in malignancies of the gastrointestinal (GI) system. However, only a fraction of sporadic GI tumors exhibit inactivating mutations in early stages of cancer formation, suggesting that other mechanisms play a critical role in the inactivation of this pathway. Here, we show a wide range of GI tumors, including those of the stomach, liver and colon in elf þ /À and elf
þ /À mutant mice. We found that embryonic liver fodrin (ELF), a b-Spectrin originally identified in endodermal stem/ progenitor cells committed to foregut lineage, possesses potent antioncogenic activity and is frequently inactivated in GI cancers. Specifically, E-cadherin accumulation at cell-cell contacts and E-cadherin-b-catenin-dependent epithelial cell-cell adhesion is disrupted in elf
þ /À mutant gastric epithelial cells, and could be rescued by ectopic expression of full-length elf, but not Smad3 or Smad4. Subcellular fractionation revealed that E-cadherin is expressed mainly at the cell membrane after TGF-b stimulation. In contrast, elf
þ /À mutant tissues showed abnormal distribution of E-cadherin that could be rescued by overexpression of ELF but not Smad3 or Smad4. Our results identify a group of common lethal malignancies in which inactivation of TGF-b signaling,
Introduction
The transforming growth factor b (TGF-b) pathway specifies diverse effects on cell growth, differentiation and lineage commitment in a wide variety of embryonic tissues. Mutational inactivation of the TGF-b pathway by sporadic mutations or in familial conditions, such as familial juvenile polyposis (JPS) and hereditary nonpolyposis coli (HNPCC), occurs during late onset, and is associated with tumorigenesis in a subset of these tissues, including the digestive tract, endometrium and the urinary tract (Derynck and Zhang, 2003; Siegel and Massague, 2003) . Mutations that inactivate the TGF-b pathway include those that impair the ability of the serine/threonine kinase TGF-b receptor II (TbRII, the target in HNPCC MMR mutations) and Smad4 (the target in JPS mutations) (Roberts and Sporn, 1990; Waite and Eng, 2003) . The result is failure to promote TGF-b receptor I (TbRI)-triggered phosphorylation of Smad2 and Smad3, followed by the associated Smad4-mediated activation of transcriptional targets, such as PAI-1, junB, the p21 cdk inhibitor, Smad7 and E-cadherin (Attisano and Wrana, 2000) .
Smad activity is modulated by a number of cofactors, such as embryonic liver fodrin (ELF), SARA, Filamin and microtubules, each of which functionally interacts with multiple other signal transduction pathways (Tsukazaki et al., 1998; Dong et al., 2000; Tang Y et al., 2003) . Adaptor proteins, such as SARA and ELF, play critical roles in the proper control of Smad access to the receptors for activation at the cell membrane, thus facilitating TGF-b functions such as growth, differentiation and cell fate specification. This is also evidenced by our observation that disruption of ELF (a b-Spectrin), in turn, disrupts TGF-b signaling as a result of mislocalization of Smad3 and Smad4 (Tang Y et al., 2003) . ELF was originally identified from endodermal stem/progenitor cells committed to foregut lineage (Mishra et al., 1998 (Mishra et al., , 1999 . Also, ELF, as a b-Spectrin and a major dynamic scaffolding protein, is important for the generation of functionally distinct membranes, protein sorting, cell adhesion and the development of a polarized differentiated epithelial cell (Tang et al., 2005) .
Multiple defects are seen in the elf À/À mutants, the majority dying at E11.5 due to gut, liver, cardiovascular and neural defects (Tang Y et al., 2003) . Aberrant gut lumen formation is seen in the elf À/À mutant embryos, whereby the lumen appears either distorted or without normal luminal columnar cells, and the cells lining the lumen being flattened and disorganized (Tang Y et al., 2003) . Our previous studies with elf À/À mutants indicate that while lineage is established early, aberrant differentiation occurs in these animals. Subsequent growth arrest may explain the smaller size of organs and the markedly abnormal phenotype that is most prominently seen in the brain, pancreas, heart and gut (Tang Y et al., 2003) . Loss of ELF is crucial for tumorigenesis, as is observed in our studies in colon cancers (Tang et al., 2005) .
The DPC4 (deleted in pancreatic carcinoma, locus 4) gene is a member of the Smad family, key downstream mediators in the TGF-b signaling pathway (Derynck and Zhang, 2003) . Loss of heterozygosity of loci on chromosome 18q occurs in a majority of colorectal cancers. The DPC4 (Smad4) tumor suppressor gene, located at 18q21.1, is functionally inactive in approximately 55% of pancreatic adenocarcinoma. In about 10-20% of colorectal tumors, DPC4 undergoes mutation (Hadzija et al., 2004) . Also, it has been shown that Smad4 þ /À heterozygous mice develop inflammatory gastric polyps and tumors at about 12 months of age, with loss of the wild-type Smad4 allele (Xu et al., 2000) . These tumors show moderate stromal cell proliferation, infiltration by eosinophils and plasma cells, as well as foci of adenocarcinoma with signet ring cells. In this model, mutations in genes such as K-Ras, H-Ras, N-Ras, p53, or PTEN are not seen. Our interest in ELF was further enhanced by its most recently discovered function as a critical regulator of TGF-bmediated activation of Smad3 and Smad4 (Tang Y et al., 2003) .
These observations led us to pursue ELF as an attractive candidate for orchestrating some steps in epithelial cell adhesion and tumor suppression. We now show a wide range of gastrointestinal (GI) tumors, including those of the stomach, liver, and colon in elf
þ /À mutant mice exhibit hyperplasia due to stimulated proliferation and suppressed apoptosis in the cells. These observations suggested that elf is an attractive candidate as a tumor suppressor of gastric cancer and prompted us to investigate this possibility. Indeed, we found that ELF possesses a potent antioncogenic activity and is frequently inactivated in GI cancers. Significantly, a dramatic disruption of Ecadherin accumulation at cell-cell contacts and epithelial cell-cell adhesion that depends on E-cadherin and b-catenin is seen in the elf þ /À /Smad4 þ /À mutants. We further demonstrate the rescue of E-cadherin-dependent homophilic cell-cell adhesion by ectopic expression of full-length elf. Our results identify a group of common lethal malignancies in which the TGF-b signaling pathway that is essential for tumor suppression is disrupted by inactivation of an adaptor protein, ELF.
Results

Wide range of GI tumors in
heterozygotes developed normally without apparent defects. Kaplan-Meier tumorfree survival curves of wild-type (control), elf
mutants when compared to the control groups ( Figure 1a ).
Histopathological examination of the tumors revealed a wide range of gut-derived tumors, from hepatocellular cancer and colonic polyps, to an exacerbated gastric hyperplasic/hamartomatous phenotype with the gastric and large bowel lesions being large and obstructing (Figure 1b-g ). The liver lesions were only seen in the elf þ /À heterozygote mutants and included early and increased centrilobular steatosis. Dysplasia was also observed in most sections, along with large nuclei with variability up to a high grade of atypia, and nuclear disarray, stratification, mitosis and apoptosis ( Figure  1k , l). Strikingly, 35% (7/20) mice developed hepatocellular carcinoma with concomitant dysplasia, nuclear changes, variability in the nuclei (Figure 1k ), abnormal mitoses ( Figure 1l ) and a distorted liver architecture. Most interestingly, 90% (18/20) 
heterozygous mutants developed an exacerbated phenotype of earlier gastric hyperplasia, ectasia, foveolar gland dysplasia, hamartomas with obstructing tumors at the antrum and pylorus (Figure 1i ). Abnormal mitoses, apoptosis and glandular dilatation were seen in the polyps and hamartomas.
ELF is expressed in GI epithelial cells. Hyperplasia and increased epithelial proliferation in elf
þ /À mice Immunohistochemical labeling for ELF in normal stomach tissues of wild-type mice shows strong expression in epithelial cells (Figure 5g and h) . In adult stomach, ELF expression was greater in the stem cell Figure 1 Wide range of gastrointestinal tumors in elf þ /À and elf Disruption of E-cadherin function by TGF-b adaptor ELF V Katuri et al zone that gives rise to parietal cells and also was more prominent in surface mucous cells than in chief cells, where proliferating cells could be labeled with 5-bromo-2 0 -deoxyuridine (BrdU). In elf þ /À /Smad4 þ /À mice, the fundic and antral areas were both enlarged and elongated (Figure 1h and i) . The stomach mucosa of these double heterozygotes was three to four times as thick as that of wild-type mucosa, and was also two to three times thicker than the elf þ /À or Smad4 þ /À mutant antral mucosa. This suggests that disruption of elf, in addition to disruption of Smad4, results in hyperplasia of the gastric mucosa. Immunohistochemical analysis of gastric epithelial proliferation by labeling day 18.5 cells with BrdU shows a significant increase in the labeling index in elf Gastric epithelial cell apoptosis is suppressed in elf þ /À /Smad4 þ /À mice Loss of response to TGF-b signaling alters apoptosis in many cells including gastric epithelial cells. We, therefore, further examined epithelial apoptosis in the developing gastric tissue by the TdT-mediated dUTPbiotin nick-end labeling (TUNEL) method as well as with anti-caspase 3 labeling. In newborn, wild-type control mice, apoptosis was noted in gastric epithelial cells that are part of the glandular structures (Figures 2e  and 3a ), but few apoptotic cells were seen in elf ELF is a localizing protein for E-cadherin at cell-cell contact sites To test whether intact ELF, once activated by TGF-b, may serve as a localizing protein for E-cadherin, we examined ELF association with E-cadherin in normal gastric antral cells. In normal, wild-type gastric antral cells, E-cadherin expression occurred at specific sites in close proximity to ELF along the cell, but this association was not robust in the absence of TGF-b stimulation (Figure 6a-c) . However, when TGF-b was added, we noted a colocalization of ELF with E-cadherin at the cell membrane within 80 min ( Figure  6d-f) . To test whether endogenous ELF binds to E-cadherin, we performed coimmunoprecipitation assays using normal gastric cell lysates (Figure 6g ). Normal gastric cell lysates (unstimulated or stimulated with TGF-b for 15 0 , 30 0 and 1 h) were subjected to immunoprecipitation (IP) with preimmune sera or an antibody against ELF and then immunoblotted (IB) Disruption of E-cadherin function by TGF-b adaptor ELF V Katuri et al Figure 6 ELF colocalizes with E-cadherin at cell-cell contact sites. (a-f) Colocalization of ELF and E-cadherin in TGF-b signaling. Gastric cells were cultured with TGF-b1 for 80 min followed by protein colocalization visualized by confocal microscopy. (a-c) ELF localization is shown with ELF antibody and Rhodamine-conjugated goat anti rabbit IgG (a, red), E-cadherin is seen with appropriate monoclonal antibodies and FITC-conjugated goat anti-mouse IgG (b, green) and overlay (c) demonstrates weak colocalization of ELF with E-cadherin at cell-cell contact sites. (d-f) Upon stimulation by TGF-b1, ELF (d, red) colocalizes with E-cadherin (e) shown in yellow at cell-cell contact sites (f, arrow). (g) Interactions of ELF, E-cadherin in gastric cells upon TGF-b stimulation. Coimmunoprecipitation assays using cell extracts from normal gastric cells, unstimulated or stimulated with TGF-b for different time points (15 0 , 30 0 and 1 h) were subjected to immunoprecipitation (IP) with preimmune sera, antibody against ELF and then immunoblotted (IB) with monoclonal antibody against E-cadherin, and vice versa. In the presence of TGF-b, coprecipitation of ELF with E-cadherin is demonstrated only at 1 h (lanes 4 and 10) when compared to the controls (lanes 6 and 12). In the absence of TGF-b, interaction between ELF and E-cadherin was not seen (lanes 1 and 7) . Immunoblot analysis demonstrates E-cadherin or ELF expression at all time points (lanes 1-4; 7-10) when compared to the negative controls (lanes 5 and 11), respectively. 
Disruption of E-cadherin function by TGF-b adaptor ELF
V Katuri et al with a monoclonal antibody against E-cadherin. The reciprocal immunoprecipitation was also performed with the same set of antibodies (Figure 6g ). Coprecipitation of ELF with E-cadherin was demonstrated in all of these cells at 1 h (Figure 6g , lanes 4 and 10) as compared to the controls (lanes 6 and 12). An interaction between ELF and E-cadherin was not observed in the absence of TGF-b (lanes 1 and 7) . Interestingly, immunoblot analysis demonstrates that E-cadherin is expressed at all time points (lanes 1-4) . Similarly, ELF is also expressed at all time points (lanes 7-10). ELF, Smad3 and E-cadherin colocalized at cell-cell contact sites upon stimulation with TGF-b (Figure 6h ). Furthermore, E-cadherin-Smad3 and E-cadherin-Smad4 coprecipitation was demonstrated in embryonic tissue lysates (Figure 7a and b) . In contrast, E-cadherin, Smad3 and Smad4 were aberrantly localized in elf À/À mutants ( Figure 8 ). To determine whether ELF associated with a-catenin and b-catenin, we immunoprecipitated endogenous ELF from cell extracts prepared from wild-type mouse embryonic fibroblasts (MEFs) and showed that ELF coprecipitated with both a-catenin and b-catenin (Figure 6i, lanes 1 and 4) . ELF may therefore serve as a protein involved in recruitment and accumulation of E-cadherin-b-catenin to cell-cell contacts.
ELF rescues E-cadherin/b-catenin substrate-independent cell-cell adhesion To define the abnormalities associated in the formation and organization of individual cell-cell contacts in elf
þ /À mutants, we used functional quantitative assays of cell-cell adhesion (Ehrlich et al., 2002) using gastric cells derived from the elf
mice. Effects on populations of cells were quantified by a hanging drop assay that measures the size of cell aggregates after being subjected to a shearing force (Kim et al., 2000) . The rate of aggregation and strength of adhesion are reflected in this assay. When cells are forced together, the close and constant apposition of cell membranes is sufficient to allow homophilic E-cadherin binding and drives cell-cell adhesion by mass action. On average, 200-400 cells were examined at each time point in each experiment. In control cells (Figure 9a ), all cells in hanging drops were initially present as single cells or clusters of fewer than 10 cells. The number of cells in large clusters (>50 cells) increased to 60% at 4 h, and to >80% after 4-6 h. Resistance to trituration increased from 0% of cells remaining in clusters of >50 cells following trituration at 4 h and to >90% of cells at 6 h after cell-cell adhesion. Large aggregates of cells had a web-like organization, as smaller clusters joined and cell-cell adhesion became condensed (Figure 9a ). Elf
þ /À mutant cells developed resistance to trituration more slowly than control cells, dispersing into clusters of fewer than 10 cells at all time points upon triturating. Mutant aggregates appeared clumpy, with little appearance of cell-cell interactions (Figure 9b) .
To explore the role of ELF in the maintenance of adherens junctions and control of gastric epithelial cell polarity, proliferation and differentiation, we investigated the possibility of rescuing E-cadherin expression and normal cell-cell adhesion in the elf
mutants through restoration of ELF activity. A fulllength elf cDNA clone was constructed that encodes the N-terminal actin and membrane binding domain, as well as the C-terminal domain that includes the ankyrin binding region, active phosphorylation sites at serine residues, and a hinge region that regulates oligomer formation (Mishra et al., 1998 (Mishra et al., , 1999 . Correction of cell-cell contacts by transient transfection of elf
þ /À gastric cells with full-length elf was confirmed by rescue of substrate independent cell-cell adhesion (Figure 9c ), but not with Smad3 or Smad4. In addition, confocal microscopy revealed that transient transfection of this full-length elf rescued E-cadherin expression (Figure 10c, arrow) , and reinstated the ability for normal cell-cell adhesion in the elf
þ /À mutant cells, which is disrupted in the mutants (Figure 10b ) when compared to the normal wild-type gastric cells (Figure 10a) .
To further confirm the disruption of E-cadherin expression and rescue by overexpression of ELF in Figure 7 E-cadherin interactions with Smad3 and Smad4. (a) Embryonic tissue lysates were immunoprecipitated (IP) with preimmune sera, and antibody to E-cadherin, and then immunoblotted (IB) with either a monoclonal or polyclonal antibody to Smad3. Coprecipitation of E-cadherin-Smad3 is observed in wildtype tissue lysates (lanes 4 and 5) when compared to the positive controls (lanes 1 and 2). In contrast, E-cadherin-Smad3 interactions were undetectable in mutants (lanes 6 and 7). (b) E-cadherin interacts with Smad4 in wild-type embryonic tissue lysates (lanes 4 and 5) when compared to the positive controls (lanes 1 and 2). E-cadherin-Smad4 interactions were undetectable in mutants (lanes 6 and 7). Figure 8 Loss of ELF function results in mislocalization of E-cadherin, Smad3 and Smad4. (a-f) Immunofluorescent confocal microscopy shows normal E-cadherin (a) expression at cell-cell contact sites (rhodamine), Smad3, cytosolic expression (c, cy5) and Smad4, cytosolic expression (e, FITC) in E11.5 wild-type gastrointestinal tissues tissue (arrow). E-cadherin (b), Smad3 (d) and Smad4 (f) distribution is abnormal in E11.5 elf À/À gastrointestinal tissue. (g-h) E-cadherin and Smad3 colocalization appears as pink (g, arrows) in E11.5 wild-type liver tissue, but not with Smad4. Scale bar (a-h) 5 mm.
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Disruption of E-cadherin function by TGF-b adaptor ELF
þ /À mutants, we used subcellular fractions (Figure 10d-f ). Normal and elf
þ /À gastric cancer cells were transiently transfected with full-length elf cDNA or vector alone. The membrane, cytosolic and nuclear fractions were collected and analysed for E-cadherin distribution with and without TGF-b1 treatment. As shown in Figure 10d , subcellular fractionation revealed that E-cadherin is present mainly at the membrane after TGF-b1 stimulation (lane 2). In contrast to the normal expression, mutants showed abnormal distribution of E-cadherin in both membrane (Figure 10d , lanes 3 and 6) and cytosol ( Figure 10f ) that was rescued by overexpression of ELF (Figure 10d , lanes 4 and e).
Discussion
Here, we demonstrate that loss of ELF, in addition to Smad4, leads to an exacerbated phenotype of earlier gastric hyperplasia with promotion of proliferation and suppression of apoptosis in epithelial cells. Furthermore, we found that ELF is inactivated in elf
þ gastric cancer cell lines. These results strongly suggest that ELF is a tumor suppressor involved in gastric cancer suppression. Finally, our findings show that ELF plays a critical role in the proper localization of E-cadherin in a subset of cells responsive to TGF-b. We provide a mechanistic insight into prior studies in other tumors that demonstrate disruption of the E-cadherin/b-catenin/fodrin/cytoskeleton and conversion from the epithelioid to the fibroblastoid phenotype (Miyaki et al., 1999; Sormunen et al., 1999; Li et al., 2003) . Our studies indicate a strong coadaptor role for ELF in TGF-b signaling leading to GI tumor suppression.
Mutational inactivation of the TGF-b pathway has been linked to the formation of tumors such as juvenile polyps with GI cancers, associated with JPS. In addition, mutations in the gene encoding TbRII have Disruption of E-cadherin function by TGF-b adaptor ELF V Katuri et al also been observed in most colorectal cancers of patients with HNPCC (Lynch syndrome). Despite a widespread inactivation of the TGF-b pathway in GI tumors, only a fraction of sporadic tumors exhibit inactivating mutations in early tumor formation, suggesting that other mechanisms play a critical role in the inactivation of this pathway.
Here, we establish such a mechanism by showing that TGF-b pathway inactivation and growth of cells from a group of gut-derived malignancies are dependent on an adaptor protein, ELF. Multiple cancers originating from meso-endodermally derived epithelium are associated with TGF-b/BMP pathway inactivation, where it may regulate progenitor cell fate. Indeed, the functions of TGF-b are more complex than simply inhibiting cell growth, as TGF-b can induce the growth of mesenchymal cells, alter synthesis of extracellular matrix components as well as metalloproteases involved in cell invasion Tang, Y et al., 2003; Waite and Eng, 2003) . TGF-b signals also modulate the immune response to tumors, and are thought to play a role in tumor angiogenesis (Shi and Massague, 2003) . Analysis of the development of gut tumors in elf þ /À and elf
þ /À mutants points to a defect in epithelial cell-cell contacts, and an inability to maintain epithelial tissue organization due to dysplastic alterations in epithelial cell morphology. These studies highlight an important role played by ELF, a b-spectrin, which acts as an essential adaptor protein, for the proper transmission of signals generated by the TGF-b pathway.
Paradoxically, TGF-b activity is also associated with increased oncogenicity in advanced human tumors, promoting invasion and motility, as well as indirect effects on angiogenesis and immune surveillance (Roberts and Sporn, 1990; Kretzschmar et al., 1999) . For instance, TGF-b mediated repression of E-cadherin with loss of E-cadherin expression results in the translocation of b-catenin from cell-cell contacts to the cytoplasm and the induction of epithelial-mesenchymal transitions, leading to an invasive phenotype (Peinado et al., 2003) . On the other hand, Smad4 induces E-cadherin with recruitment of catenins to the plasma membrane (Muller et al., 2002) . Aberrant distribution of nonerythroid b-Spectrins, in association with loss of membranous E-cadherin, has been described in high-grade carcinomas with poor prognosis (Sormunen et al., 1999) . Genetic alterations leading to a loss of genes encoding E-cadherin (Guilford et al., 1998) , as well as silencing of RUNX (Li et al., 2002) , have been described. It was, therefore, of interest to determine the importance of ELF in cell-cell adhesion mediated by TGF-b signaling. The aberrant localization and decreased levels of E-cadherin (Figure 4c and d) and b-catenin (Figure 5b ) in the elf
þ /À mutants were particularly interesting in view of the tumor suppressor role of E-cadherin (Li et al., 2002) . Lack of E-cadherin accumulation at cell-cell contacts results in loss of b-catenin localization to cell-cell contacts, leading to an epithelioid morphology, decreased calcium dependent cell aggregation, and increased cell motility. This abnormality could induce the scattered morphology and the invasive nature of diffuse gastric and hepatocellular cancers (Sormunen et al., 1999; Muller et al., 2002) .
In diffuse-type gastric carcinoma, an important molecular mechanism determining its histologic phenotype is thought to be loss of E-cadherin-mediated cellcell adhesion. Several means of silencing E-cadherin gene expression in gastric carcinoma have been observed, including methylation of the E-cadherin promoter, E-cadherin gene truncation mutations and loss of heterozygosity of the E-cadherin locus (Rosivatz et al., 2002; Brooks-Wilson et al., 2004; Scartozzi et al., 2004; Yang et al., 2004) . However, these mechanisms account for only a portion of the E-cadherin-negative gastric carcinomas. Our observation that loss of ELF expression is associated with invasive gastric carcinoma provides the first indication that induction of E-cadherin localization by such cytoskeletal/adaptor factors plays a role in suppression of these tumors.
The results from these studies shed insight into prior studies that demonstrate accumulation of E-cadherinmediated adherens junctions, the membrane cytoskeleton, and the Na/K-ATPase and their regulation through sequential protein expression (Piepenhagen and Nelson, 1998; Nelson and Hammerton, 1989) . The hierarchy of events leading to polarized protein stabilization and accumulation is, however, unclear. For instance, the establishment of spatial coordinates during the differentiation of polarized cells involves a positional cue from cadherins that results in the targeting of a and b-Spectrin to a discrete plasma membrane domain. Spectrin tetramers become linked directly or indirectly to a number of integral proteins, such as members of the L1 cell adhesion protein family, to specific points on cell membranes. The spectrin tetramer is then able to capture and stabilize additional membrane interacting proteins, forming the characteristic profile of a polarized membrane domain (Mishra et al., 1998; Bennett and Baines, 2001) .
In the ureteric bud, for example, the distribution of Spectrin (fodrin) undergoes dramatic changes during the development of a continuous monolayer (Pinder and Baines, 2000) . The model for the assembly and localization of the membrane cytoskeleton and Na/K-ATPase was considered to be as follows: before induction of the ureteric bud, mesenchymal cells express abundant a and b-Spectrin. Induction then results in E-cadherin expression. Newly synthesized E-cadherin immediately binds to cytosolic a and b-Spectrin and is transported to the cell surface where it forms homotypic contacts with E-cadherin molecules on adjacent cells, whereby the future lateral plasma membrane is defined. At slightly later times, ankyrin expression begins, allowing Na/ K-ATPase to be recruited to the membrane in these studies. Genetic methods now provide an opportunity to test this model. In our mouse model, where ELF, a non-PH domain b-spectrin with unique 5 0 and 3 0 exons is specifically disrupted, we have been able to confirm loss of ELF by a number of approaches as described previously and in this study (Tang Y et al., 2003 and Figure 10g ). In addition, the elf knockout phenotype
Disruption of E-cadherin function by TGF-b adaptor ELF V Katuri et al reinforces analyses demonstrating the role of b-spectrins, and more recently ELF, in Na/K-ATPase localization (Nelson and Hammerton, 1989; Tang Y et al., 2005) . Indeed, the collective studies examining normal ELF function (utilizing peptide-specific ELF antibodies) and rescue studies further corroborate the remarkable role of this b-spectrin in linking TGF-b signaling with E-cadherin induced tumor suppression.
Our studies indicate that ELF is significantly involved in targeting of proteins such as E-cadherin to the plasma membrane of polarized epithelial cells. Indeed, a dramatic loss of E-cadherin-induced cell-cell adhesion is seen in the elf mutant cells. Thus, while initial spatial cues are most probably determined by the cadherins, b-Spectrins, such as ELF, play a major role in recruiting further E-cadherin molecules to the lateral membrane of the cell surface and, potentially, the development of a continuous monolayer. Taken together, these studies are consistent with the role for the spectrin skeleton in stabilizing membrane proteins and preventing their endocytosis after delivery to the membrane. It is possible that spectrin also interacts within the secretory pathway to sort E-cadherin and other proteins before its arrival at the cell membrane, and it will be important to address these issues in future studies (Nelson and Hammerton, 1989; Fath et al., 1997; Nelson and Nusse, 2004) . These results establish a mechanistic link between TGF-b signaling/ELF, E-cadherin/b-catenin, as well as a surprising link between two major pathways in gut epithelial cell differentiation and tumor suppression. These studies also demonstrate that loss of ELF expression plays an important role in the development of GI tumors, which are among the most lethal forms of cancers.
Materials and methods
Mice
Elf þ /À mice were intercrossed with Smad4 þ /À mice to obtain elf
þ /À mutations were maintained on a mixed 129SvEv/Black Swiss background. The presence of mutations was monitored by use of the polymerase chain reaction as described previously (Tang Y et al., 2003) . Animal care was in accordance with institutional guidelines, and under approved animal care protocols.
Statistical analysis
Survival time of mice was measured from the date of birth until the date of death or killing. Kaplan-Meier cumulative tumor-free survival curves were plotted and compared pair wise by standard statistical rank tests using StatView software.
Histological analysis and antibody staining Any tumors identified were dissected, fixed with 4% paraformaldehyde, dehydrated, embedded in paraffin and sectioned at 6 mm. Sections were stained with hematoxylin and eosin (H&E), to confirm histological characterization. Immunohistochemical staining was performed as described previously (Tang et al., 2005) with primary antibodies against ELF, E-cadherin, b-catenin (BD Biosciences, Santa Cruz, CA, USA), H/K-ATPase (Research Diagnostics), and RUNX (Oncogenic Research Products). Sections were then incubated with peroxidase-conjugated secondary antibodies (Jackson Immunoresearch Laboratories, USA) of appropriate specificity and processed for immunostain using diaminobenzidine (Sigma) and counterstaining was performed with modified Harris hematoxylin solution (Sigma). All tissue sections were photographed with digital camera (Spot insight color, model# 3.2.0) mounted to a microscope (Olympus, BH2-RFCA).
Detection of proliferating cells
Proliferating cells were labeled with BrdU by using BrdU labeling and detection kit (Zymed). BrdU (1 ml/100 g body weight) was injected (i.v) into 18.5 dpc pregnant mice, and 4 h later the fetal stomachs were fixed with 4% paraformaldehyde, embedded in paraffin, and sectioned at 6 mm.
Detection of apoptotic cells Apoptotic cells were detected by the TUNEL method with an MEB STAIN Apoptosis Kit Direct (MBL, 8445), as well as with antiactive caspase 3 antibody (Promega, Madison, WI, USA). Tissues were then fixed and analysed by using immunofluorescence microscopy (Olympus, BH2-RFCA).
Generation of gastric cells
Normal and gastric cancer tissue were dissected out from elf
þ /À mice cleansed of blood, food, feces and washed with PBS were collected and cultured in 10 ml medium containing 10% calf serum and 10 mg/ml insulin. After 24 h, the cell lines were propagated in Dulbecco's modified Eagle' medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/ml pencillin, 100 mg/ml streptomycin, 0.2 mg/ml p-hydroxybenzoic acid, 10% calf serum, 10 mg/ ml insulin and 20 mg/ml collagenase to establish wild type, Smad4 þ /À and elf þ /À /Smad4 þ /À gastric cancer cell lines that were cultured over multiple passages to obtain sufficient cells to perform the experiments. Gastric epithelial cell morphology was confirmed with H/K-ATPase antibody labeling (a marker for gastric parietal cells). The gastric cells used for the experiments were at passage 3-15. This method was kindly provided to us by Dr Jonathan Blay, Dalhousie University, Halifax, Nova Scotia. Three different elf þ /À
/Smad4
þ /À and one Smad4 þ /À gastric cancer cell lines were tested in different experiments, and the results obtained were also independent of passage number. Representative data are shown.
Cruz, CA, USA). Western blot analysis was performed using a total of four separate antibodies: two peptide specific antibodies to ELF, peptide-specific antibody that detects nonerythroid b-Spectrins, as well as an antibody that recognizes nonerythroid b-2-Spectrin (a kind gift from Drs R Bloch and J Morrow). The loading control was performed under the same conditions using anti-Actin (Santa Cruz, CA, USA).
Hanging drop adhesion assay
The assay was performed as described (Kim et al., 2000) . Briefly gastric cells derived from the elf þ /À
/Smad4
þ /À as well as wild-type cells were grown at low density and elf expression was induced as appropriate. Cells were trypsinised, centrifuged and resuspended as single-cell suspensions at 2.5 Â 10 5 cells/ml. In total, 20 ml drops of cell suspension were pipetted onto the inside surface of 35-mm culture dish lids, and dishes were filled with 2 ml of media to prevent evaporation. At each time point, the lid was inverted and drops were separated on to a glass slide. One drop was first triturated 10 times through a 20 ml pipet. Three random fields from each drop were photographed (Olympus), and numbers and sizes of clusters were determined. For each time point, 200-400 cells were scored and data are presented as the average of three independent experiments.
Transient transfection assays
For the transient expression assays, the cells were seeded at a density of 2 Â 10 5 cells/well in six-well dishes and were then transfected using full-length elf or vector alone (3 mg of DNA per well) using Effectene as a transfection reagent (Qiagen). Following transfections, cells were washed with Â 2 DMEM after 12-18 h and subsequently treated with TGF-b1 (100 pmol/l) and incubated for 1 h. Cells were then fixed and analysed by confocal microscopy as above or used for subcellular fractionation. All experiments were repeated at least three times, and similar results were obtained each time.
Subcellular fractionation
Normal and gastric cancer cells were harvested and membrane, cytosolic and nuclear fractions were prepared using ProteoExtract-Subcellular Proteome Extraction kit (Calbiochem, La Jolla, CA, USA). Briefly, cells were harvested and washed twice with washing buffer and incubated for 5 min at 41C under gentle agitation. The cells were then mixed with 1 ml extraction buffer I and 5 ml protease inhibitor cocktail and incubated for 10 min at 41C and transferred the supernatant (fraction 1) in a new tube after centrifiguation for collection of cytosolic protein extract. Subsequently, residue material was further processed according to the manufacturer's protocol for collection of membrane and nuclei protein extracts. All samples were analysed by Western blot as described previously (Tang Y et al., 2003) using anti-E-cadherin antibody. The data shown represent three individual experiments.
Abbreviations ELF, embryonic liver fodrin; TGF-b, transforming growth factor-b; TbRII, transforming growth factor-b receptor II; TbRI, transforming growth factor-b receptor I; MEFs, mouse embryonic fibroblasts; HNPCC, hereditary nonpolyposis colorectal cancer; BrdU, 5-bromo-2 0 -deoxyuridine; TUNEL, TdT-mediated dUTP-biotin nick-end labeling.
